CAR-T cell therapy is a type of immunotherapy that involves collecting T cells (a type of immune cell) from your body, genetically modifying them in a lab to target and attack multiple myeloma cells, and then reintroducing them to your body. This therapy is designed to help your immune system fight cancer more effectivel... read more

CAR-T cell therapy is a type of immunotherapy that involves collecting T cells (a type of immune cell) from your body, genetically modifying them in a lab to target and attack multiple myeloma cells, and then reintroducing them to your body. This therapy is designed to help your immune system fight cancer more effectively. It's particularly considered for patients whose myeloma is refractory (resistant to other treatments) or has relapsed.

Given your age and treatment history, it's crucial to discuss this option thoroughly with your healthcare provider to understand the potential benefits and risks, including the possibility of serious side effects like cytokine release syndrome. This therapy represents a significant advancement in treating multiple myeloma, especially for those who have tried multiple other treatments.

 This AI-generated response comes from MyMyelomaTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

CAR-T Cell Therapy for Multiple Myeloma: What Is It? | MyMyelomaTeam

Gene-Based Therapy May Thwart a Tough Blood Cancer | MyMyelomaTeam